Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Nvelop Therapeutics is a biotechnology company that developes genetic medicines for patients with severe genetic diseases.
Radionetics Oncology is a pharmaceutical company that focuses on the discovery and development of novel radiotherapeutics.
Nido Biosciences is a clinical-stage company that develops precision medicines for severe neurological diseases.
Escient Pharmaceuticals is a privately-held biotechnology company focusing on the advancement of G Protein-Coupled Receptor targeted drugs.
Novome Biotechnologies is a biotechnology company focused on engineering defined activities into the human.
CinCor is a clinical-stage biopharmaceutical company that develops treatments for cardiovascular diseases.
Portal Instruments is an early stage company that offers medical device.
Pear Therapeutics is a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals.
A private biopharmaceutical company .
Soteria is a biotechnology company that develops immunotherapies to treat cancer patients
Purigen Biosystems' innovative products offer a truly transformative automated solution for DNA and RNA purification.
Inipharm is a biopharmaceutical company.
Homology Medicines is a genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases.
Precision NanoSystem provides Neuro9Kit for the study of gene function in neurons and glia cells.
NodThera is a biotechnology company focused on the discovery and development of new treatments for diseases.
Akouos is a biotechnology company focusing on restoring and preserving hearing.
Millendo Therapeutics is a biopharmaceutical company previously primarily focused on developing novel treatments for endocrine diseases.
Cleave Therapeutics is focused on protein homeostasis and stress pathways in cancer and neurodegeneration.
Nohla Therapeutics is a biotechnology company that develops a shelf alternative to bone marrow transplants.
Calibrium is an emerging privately held biopharmaceutical company.
5AM Ventures has invested in 68 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
5AM Ventures's top investment sectors include Biotechnology, Health Care, Pharmaceutical, Therapeutics, Medical. The firm invests across 17 different industry categories.
Among tracked funding rounds, CinCor Pharma received $225.0M in a Post Ipo Equity round. 5AM Ventures's total known invested capital is $5.6B.
5AM Ventures's average investment size is $107.3M across its portfolio of 68 companies.
Recent 5AM Ventures portfolio additions include Nvelop Therapeutics, Radionetics Oncology, Nido Biosciences, Escient Pharmaceuticals, Novome Biotechnologies. These companies were founded in 2020 or later.